表纸
市场调查报告书

抗菌药的全球市场 - 产业洞察,市场趋势,预测,市场机会分析 2016年~2024年

Antibacterial Drugs Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

出版商 Coherent Market Insights 商品编码 798090
出版日期 内容资讯 英文 156 Pages
商品交期: 2-3个工作天内
价格
Back to Top
抗菌药的全球市场 - 产业洞察,市场趋势,预测,市场机会分析 2016年~2024年 Antibacterial Drugs Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024
出版日期: 2019年02月26日内容资讯: 英文 156 Pages
简介

抗菌药,用于由于气候的变化,及发展中国家的卫生状态恶劣等要素而引起的细菌性感染疾病的治疗或预防。抗菌药相关的主要课题,是细菌持有抗菌药抗性。为了对应抗生素抗药性菌的课题,针对新的抗菌药的开发进行重要的研究。

本报告提供全球抗菌药市场调查,市场概要,各医药品分类、给药途径、流通管道、地区的市场规模的变化与预测,市场成长要素及阻碍因素分析,市场机会,竞争情形,主要企业的简介等全面性资讯。

目录

第1章 调查目的与前提条件

  • 调查目的
  • 前提条件
  • 简称

第2章 市场范围

  • 报告概要
    • 市场定义和范围
  • 摘要整理
    • 市场片段:各医药品分类
    • 市场片段:各给药途径
    • 市场片段:各流通管道
    • 市场片段:各地区
  • Coherent Opportunity Map(COM)

第3章 市场动态,法规,趋势分析

  • 市场动态
    • 成长要素
    • 阻碍因素
    • 市场机会
  • 影响分析
  • 开发平台分析
  • 偿付方案
  • 流行病学
  • PESTEL分析
  • 法规方案
  • 新产品的销售
  • 联盟、协定
  • 市场趋势

第4章 全球抗菌药市场:各医药品分类

  • 简介
  • β-内醯胺
  • 奎诺酮类抗生素(Quinolones)
  • 大环内酯类
  • 四环霉素
  • Aminoglycosides
  • 磺胺类药物
  • 氯霉素
  • 其他

第5章 全球抗菌药市场:各给药途径

  • 简介
  • 口服
  • 局部
  • 非口服
  • 其他

第6章 全球抗菌药市场:各流通管道

  • 简介
  • 医院药局
  • 零售药局
  • 线上药局

第7章 全球抗菌药市场:各地区

  • 简介
  • 北美
  • 中南美
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第8章 竞争环境

  • 热图分析
  • 企业简介
    • Novartis AG
    • Allergan
    • Bristol Myers Squibb Company
    • AstraZeneca
    • Johnson and Johnson
    • Merck & Co., Inc.
    • GlaxoSmithKline Plc.
    • Sanofi SA
    • Bayer AG
    • Pfizer Inc.
  • 分析师的意见

第9章 Section

  • 参考文献
  • 调查方法
  • 关于Coherent Market Insights
目录

Antibacterial drugs are used in treatment or prohibition of bacterial infections caused due to various factors such as climatic changes, unhygienic lifestyle specially in emerging economies and others. Major challenge associated with antibacterial drugs is resistance of bacteria towards it. Significant studies are carried out to develop new antibacterial drugs to combat these problems.

Market Dynamics

Increasing prevalence of infectious diseases is a major factor driving antibacterial drugs market growth. According to World Health Organization (WHO), September 2018, annually around 11 million to 21 million cases of typhoid fever are reported worldwide. Moreover, growing geriatric population susceptible to high risk of bacterial infection, majorly caused due to age related changes in immunology is expected to boost the market growth. The Current Opinion in Microbiology Journal 2016, stated Lower respiratory tract infection (Pneumonia), as the most common cause of infection disease in older patients in the U.S. and estimated it as 6 leading cause of death in the U.S.

However, price control of antibacterial drugs, genetic mutation in aging population, and decrease in financial incentives has distracted the focus of pharmaceutical companies from research and development of antibacterial drugs. In September 2016, AstraZeneca announced an agreement with Pfizer to sell the development and commercialization rights to its late-stage small molecule antibiotics business as AstaZeneca does not find antibiotic research as major area for development in their business

Key features of the study:

  • This report provides in-depth analysis of the antibacterial drugs market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017, as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global antibacterial drugs market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Novartis AG, Allergan, Bristol Myers Squibb Company, AstraZeneca, Johnson and Johnson, Merck & Co., Inc., GlaxoSmithKline Plc. (GSK), Sanofi, Bayer AG, and Pfizer Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
  • The global antibacterial drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the antibacterial drugs market

Detailed Segmentation

  • Global Antibacterial Drugs Market, By Drug class:
    • Beta lactams
    • Quinolones Macrolides
    • Tetracycline
    • Aminoglycoside
    • Sulfonamide
    • Phenicols
    • Others
  • Global Antibacterial Drugs Market, By Route of Administration:
    • Oral
    • Topical
    • Parenteral
    • Others
  • Global Antibacterial Drugs Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Antibacterial Drugs Market, By Geography:
    • North America
      • By Drug Class:
      • Beta lactams
      • Quinolones Macrolides
      • Tetracycline
      • Aminoglycoside
      • Sulfonamide
      • Phenicols
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Parenteral
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Drug Class:
      • Beta lactams
      • Quinolones Macrolides
      • Tetracycline
      • Aminoglycoside
      • Sulfonamide
      • Phenicols
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Parenteral
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Drug Class:
      • Beta lactams
      • Quinolones Macrolides
      • Tetracycline
      • Aminoglycoside
      • Sulfonamide
      • Phenicols
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Parenteral
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Drug Class:
      • Beta lactams
      • Quinolones Macrolides
      • Tetracycline
      • Aminoglycoside
      • Sulfonamide
      • Phenicols
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Parenteral
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Drug Class:
      • Beta lactams
      • Quinolones Macrolides
      • Tetracycline
      • Aminoglycoside
      • Sulfonamide
      • Phenicols
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Parenteral
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Drug Class:
      • Beta lactams
      • Quinolones Macrolides
      • Tetracycline
      • Aminoglycoside
      • Sulfonamide
      • Phenicols
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Parenteral
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Novartis AG *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Allergan
    • Bristol Myers Squibb Company
    • AstraZeneca
    • Johnson and Johnson
    • Merck & Co., Inc.
    • GlaxoSmithKline Plc.
    • Sanofi SA
    • Bayer AG
    • Pfizer Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Class
    • Market Snippet, By Route of Administration
    • Market Snippet, By Distribution channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • Reimbursement Scenario
  • Epidemiology
  • Pest Analysis
  • Regulatory Scenario
  • New Product Launches
  • Collaborations and Agreements
  • Market Trends

4. Global Antibacterial Drugs Market, By Drug Class, 2018 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Beta lactams
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Quinolones
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Macrolides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Tetracyclines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Aminoglycosides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Sulphonamides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Phenicols
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)

5. Global Antibacterial Drugs Market, By Route of Administration, 2018 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Parenteral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)

6. Global Antibacterial drugs Market, By Distribution Channel, 2018 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)

7. Global Antibacterial Drugs Market, By Region, 2018 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Drug Class, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Drug Class, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Drug Class, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Drug Class, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Drug Class, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Drug Class, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Novartis AG
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Allergan
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bristol Myers Squibb Company
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AstraZeneca
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson and Johnson
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck & Co., Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GlaxoSmithKline Plc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi SA
    • Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bayer AG
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pfizer Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top